APA (7th ed.) Citation

M, T., Y, K., K, K., H, S., T, J., K, T., . . . H, T. (2024). Development of a Neopentyl 211At-Labeled Activated Ester Providing In Vivo Stable 211At-Labeled Antibodies for Targeted Alpha Therapy. ChemMedChem, 19(18), e202400369. https://doi.org/10.1002/cmdc.202400369

Chicago Style (17th ed.) Citation

M, Tada, Kaizuka Y, Kannaka K, Suzuki H, Joho T, Takahashi K, Uehara T, and Tanaka H. "Development of a Neopentyl 211At-Labeled Activated Ester Providing In Vivo Stable 211At-Labeled Antibodies for Targeted Alpha Therapy." ChemMedChem 19, no. 18 (2024): e202400369. https://doi.org/10.1002/cmdc.202400369.

MLA (9th ed.) Citation

M, Tada, et al. "Development of a Neopentyl 211At-Labeled Activated Ester Providing In Vivo Stable 211At-Labeled Antibodies for Targeted Alpha Therapy." ChemMedChem, vol. 19, no. 18, 2024, p. e202400369, https://doi.org/10.1002/cmdc.202400369.